Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea
· Delayed Price · Currency is KRW 10,810
-60 (-0.55%)
Apr 29, 2026, 3:30 PM KST
Daewon Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 47,196 | 17,057 | 29,982 | 26,970 | 41,697 | Upgrade
|
| Short-Term Investments | 29,279 | 29,051 | 47.71 | 20,036 | 13,123 | Upgrade
|
| Cash & Short-Term Investments | 76,475 | 46,108 | 30,030 | 47,006 | 54,820 | Upgrade
|
| Cash Growth | 65.86% | 53.54% | -36.11% | -14.26% | 421.08% | Upgrade
|
| Accounts Receivable | 77,119 | 73,355 | 70,602 | 62,533 | 52,102 | Upgrade
|
| Other Receivables | 2,591 | 4,317 | 2,580 | 3,906 | 2,363 | Upgrade
|
| Receivables | 80,293 | 77,877 | 73,382 | 66,840 | 54,584 | Upgrade
|
| Inventory | 97,832 | 113,166 | 105,078 | 91,847 | 69,690 | Upgrade
|
| Prepaid Expenses | 759.55 | 716.31 | 488.39 | 426.61 | 353.29 | Upgrade
|
| Other Current Assets | 1,243 | 1,486 | 314.56 | 1,165 | 929.46 | Upgrade
|
| Total Current Assets | 256,603 | 239,353 | 209,293 | 207,284 | 180,377 | Upgrade
|
| Property, Plant & Equipment | 222,902 | 208,378 | 160,092 | 158,912 | 166,674 | Upgrade
|
| Long-Term Investments | 56,898 | 48,621 | 84,647 | 36,443 | 28,081 | Upgrade
|
| Goodwill | 6,000 | 5,549 | 7,254 | 11,328 | 11,549 | Upgrade
|
| Other Intangible Assets | 30,693 | 29,191 | 16,121 | 13,603 | 13,916 | Upgrade
|
| Long-Term Deferred Tax Assets | 12,452 | 8,540 | 7,985 | 6,694 | 9,616 | Upgrade
|
| Long-Term Deferred Charges | 25,783 | 20,057 | 18,096 | 15,142 | 14,977 | Upgrade
|
| Other Long-Term Assets | 2,320 | 23,701 | 4,510 | 4,144 | 4,390 | Upgrade
|
| Total Assets | 613,651 | 583,389 | 507,998 | 453,550 | 429,580 | Upgrade
|
| Accounts Payable | 30,283 | 20,913 | 20,910 | 19,583 | 17,222 | Upgrade
|
| Accrued Expenses | 6,226 | 5,686 | 4,885 | 4,352 | 3,741 | Upgrade
|
| Short-Term Debt | 105,740 | 106,035 | 69,651 | 52,768 | 42,543 | Upgrade
|
| Current Portion of Long-Term Debt | 9,477 | 12,917 | 39,803 | 9,284 | 8,822 | Upgrade
|
| Current Portion of Leases | 1,864 | 1,800 | 1,123 | 1,344 | 362.95 | Upgrade
|
| Current Income Taxes Payable | 487.51 | 4,403 | 2,485 | 4,913 | 4,367 | Upgrade
|
| Other Current Liabilities | 62,261 | 49,023 | 43,833 | 35,903 | 25,019 | Upgrade
|
| Total Current Liabilities | 216,337 | 200,776 | 182,690 | 128,146 | 102,076 | Upgrade
|
| Long-Term Debt | 82,870 | 63,626 | 34,575 | 52,119 | 69,625 | Upgrade
|
| Long-Term Leases | 2,085 | 2,863 | 897.72 | 961.42 | 2,616 | Upgrade
|
| Pension & Post-Retirement Benefits | 31,205 | 27,792 | 25,497 | 23,478 | 36,780 | Upgrade
|
| Other Long-Term Liabilities | 6,576 | 3,753 | 73.5 | 80 | 80 | Upgrade
|
| Total Liabilities | 339,073 | 298,811 | 243,734 | 204,785 | 211,176 | Upgrade
|
| Common Stock | 11,214 | 11,214 | 11,095 | 10,982 | 10,612 | Upgrade
|
| Additional Paid-In Capital | 17,962 | 17,161 | 13,483 | 11,789 | 9,530 | Upgrade
|
| Retained Earnings | 251,407 | 262,077 | 255,790 | 241,595 | 204,827 | Upgrade
|
| Treasury Stock | -15,100 | -15,063 | -15,063 | -15,063 | -8,891 | Upgrade
|
| Comprehensive Income & Other | 435.68 | -104.76 | 892.92 | 1,643 | 3,221 | Upgrade
|
| Total Common Equity | 265,918 | 275,285 | 266,199 | 250,947 | 219,299 | Upgrade
|
| Minority Interest | 8,660 | 9,294 | -1,934 | -2,182 | -894.85 | Upgrade
|
| Shareholders' Equity | 274,578 | 284,578 | 264,264 | 248,765 | 218,404 | Upgrade
|
| Total Liabilities & Equity | 613,651 | 583,389 | 507,998 | 453,550 | 429,580 | Upgrade
|
| Total Debt | 202,034 | 187,241 | 146,050 | 116,476 | 123,968 | Upgrade
|
| Net Cash (Debt) | -125,559 | -141,133 | -116,020 | -69,471 | -69,148 | Upgrade
|
| Net Cash Per Share | -5858.09 | -6629.05 | -5356.37 | -3175.72 | -3258.76 | Upgrade
|
| Filing Date Shares Outstanding | 21.43 | 21.43 | 21.2 | 20.97 | 20.6 | Upgrade
|
| Total Common Shares Outstanding | 21.43 | 21.43 | 21.2 | 20.97 | 21.22 | Upgrade
|
| Working Capital | 40,266 | 38,577 | 26,603 | 79,137 | 78,301 | Upgrade
|
| Book Value Per Share | 12406.70 | 12843.70 | 12558.89 | 11966.66 | 10335.27 | Upgrade
|
| Tangible Book Value | 229,226 | 240,544 | 242,823 | 226,017 | 193,833 | Upgrade
|
| Tangible Book Value Per Share | 10694.77 | 11222.85 | 11456.07 | 10777.82 | 9135.12 | Upgrade
|
| Land | 51,414 | 51,414 | 36,957 | 36,957 | 37,055 | Upgrade
|
| Buildings | 145,397 | 122,341 | 107,803 | 107,710 | 79,558 | Upgrade
|
| Machinery | 138,403 | 114,900 | 101,791 | 100,149 | 41,553 | Upgrade
|
| Construction In Progress | 11,630 | 29,613 | 10,692 | 778.36 | 1,585 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.